Concepedia

Author

Bei Wang

Dana-Farber Cancer InstituteORCID

Also Known As

Bei Wang

9

Publications

473

Citations

6

H-Index

14

Concepts

All Affiliations

Dana-Farber Cancer InstituteSarah Cannon
BW

About

Bei Wang is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

67

2

Pharmacology

2

2

67

3

Immunology

1

1

25

4

Cancer Therapeutics

1

1

42

5

Drug Discovery

1

1

25

Bei Wang

×

6

Publications

469

Citations

6

H-Index

YearCitations

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Sandhya Girish, Manish Gupta, Bei Wang,

Cancer Chemotherapy and Pharmacology

2012

261

Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

Shu‐Ying Chang, Wenying Li, Sarah C. Traeger,

Drug Metabolism and Disposition

2008

59

Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies

Chunze Li, Cindy Zhang, Zao Li,

mAbs

2019

53

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

Dan Lu, Amita Joshi, Bei Wang,

Clinical Pharmacokinetics

2013

42

Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity

Bei Wang, Arabella Wan, Yu Xu,

Nature Communications

2023

29

Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics

Siddharth Sukumaran, Crystal Zhang, Douglas D. Leipold,

The AAPS Journal

2016

25

Page 1